Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for more on REGN stock news.

Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of ...

Attorney Stuart Silverman says the First Circuit’s widening the divide on the False Claims Act’s causation standard adds to the need for the Supreme Court to weigh in.

"One of the approaches I used in my project was bridging western medicine and also traditional indigenous practices." ...

This was the stock's third consecutive day of losses.

Celestial discoveries: Paz won the $250,000 top prize for his research on detecting objects in the night sky. Using ...